Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib in CIN 2/3
NCT00081263Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Jun 2005
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of celecoxib oral solution in cervical intraepithelial neoplasia (CIN) (2 arms), sponsored by GOG Foundation. Primary endpoints: Histologic Regression and Incidence of Adverse Effects (Grade 3 or Higher) up to 18 weeks. Started Jun 2005; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT00081263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00081263.